Company Filing History:
2 out of 11 
2 out of 2 
1 out of 16 
Years Active: 2004-2022
Title: Per Venge: Innovator in Analyte Detection Technology
Introduction
Per Venge, an accomplished inventor based in Uppsala, Sweden, has made significant contributions to the field of analyte detection. With a total of 8 patents to his name, Venge's work is characterized by a strong focus on diagnostic methodologies that enhance the accuracy and efficiency of infection detection.
Latest Patents
Among his latest innovations, Venge has developed an "Analyte Detection System and Method." This patented system facilitates the detection of specific analytes in a sample by incorporating a measurement chamber, heating elements, sensors, and a processor. It effectively measures the presence and concentration of the desired analyte by utilizing known interaction kinetics under controlled conditions. Additionally, he holds a patent for a "Diagnostic Method Employing HNL," which addresses the detection of bacterial infections and aids in differentiating between viral and bacterial infections. This method utilizes specific binding agents to identify epitopes of human neutrophil lipocalin (HNL), helping to monitor antibiotic therapy and stratify patients for treatment.
Career Highlights
Throughout his career, Per Venge has collaborated with notable companies in the medical technology field, including Siemens Healthineers Nederland B.V. His innovations have significantly advanced diagnostic capabilities, assisting in the rapid identification and management of infections.
Collaborations
Venge’s work has been enriched by collaboration with skilled professionals such as Markus Hendrikus Van Roosmalen and Jeroen Hans Nieuwenhuis. These partnerships have allowed for the innovative development of diagnostic tools that are crucial in healthcare.
Conclusion
With a strong foundation in analyte detection technologies, Per Venge continues to impact the field of diagnostics significantly. His patents are critical in enhancing the detection methods utilized in medical institutions, reinforcing his status as a leading inventor in the domain of health-related innovations.